ViroCell Biologics has successfully completed an oversubscribed financing round through a convertible note offering. The proceeds will be used to accelerate ViroCell's growth amid strong demand for its specialized services in viral vector design and manufacturing.

Dorset Opportunity Fund Lp

Sartorius Stedim Biotech S.A.

First Light Asset Management Llc

ViroCell Biologics is an innovation-driven Contract Development and Manufacturing Organization (CDMO) that manufactures viral vectors and gene-modified cells to enable novel cell and gene therapies to enter clinical trials.




virocell.com

London

Virocell Biologics Ltd

ViroCell Biologics completed an oversubscribed convertible note offering led by First Light Asset Management LLC to accelerate its growth in viral vector manufacturing services.

ViroCell Biologics completed an oversubscribed convertible note offering led by First Light Asset Management LLC to accelerate its growth in viral vector manufacturing services.

Investors

Description

Company Information

Related People

Funding Insights

ViroCell Biologics completed an oversubscribed convertible note offering led by First Light Asset Management LLC to accelerate its growth in viral vector manufacturing services.

Investors

Description

.css-1v6jzuu{--tw-text-opacity:1;color:rgba(75, 85, 99, var(--tw-text-opacity));}Company Information

Related People

Funding Insights

Company Information